Lv5
910 积分 2022-10-23 加入
Size-Dependent In Vivo Transport of Nanoparticles: Implications for Delivery, Targeting, and Clearance
1个月前
已完结
Targeting Polymeric Nanoparticles to Specific Cell Populations in the Liver
1个月前
已完结
Selective organ targeting nanoparticles: from design to clinical translation
1个月前
已完结
Controlling the biodistribution and clearance of nanomedicines
1个月前
已完结
Activation of CYP3A by Accelerated Blood Clearance Phenomenon Potentiates the Hepatocellular Carcinoma-Targeting Therapeutic Effects of PEGylated Anticancer Prodrug Liposomes
1个月前
已完结
Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications
1个月前
已完结
Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models
1个月前
已完结
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
1个月前
已完结
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
1个月前
已完结
Advanced materials for non-alcoholic fatty liver disease and cardiovascular disease comorbidity therapeutics
1个月前
已完结
皖公网安备34019202002308
